CIK: 1826323 - Address: C/o Essa Pharma Inc., 999 West Broadway, Suite 720, Vancouver, A1 V5Z 1K5
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/8/23 20:31
11/7/23
EVLOEvelo Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsThorell MarellaMAOCFOM.d00.00074122D
11/8/23 20:31
11/8/23
EVLOEvelo Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsThorell MarellaMAOCFOS.d-10.33000-2-822D
11/3/23 16:11
11/1/23
EVLOEvelo Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsThorell MarellaMAOCFOM.d00.0001324718D
11/3/23 16:11
11/2/23
EVLOEvelo Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsThorell MarellaMAOCFOS.d-10.33000-4-1918D
8/9/23 20:42
8/7/23
EVLOEvelo Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsThorell MarellaMAOCFOM.d00.00072539D
8/9/23 20:42
8/8/23
EVLOEvelo Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsThorell MarellaMAOCFOS.d-199.510-2-189D
5/10/23 21:31
5/8/23
EVLOEvelo Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsThorell MarellaMAOCFOS-50.12550-39-3091D
5/9/23 16:09
5/7/23
EVLOEvelo Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsThorell MarellaMAOCFOM.d00.000130New130D
6/4/21 17:00
6/2/21
CNTACentessa Pharmaceuticals PlcX0HealthDrugPharmaceutical PreparationsThorell MarellaX0OChief AcP2020.0001New1D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact